CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 179 enrolled
Drug / intervention
Motivational Interviewing and Guided Opioid Tapering Support +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03659734
NCT03659734N/ACompleted

Randomized Controlled Trial to Evaluate the Relative Efficacy of Motivational Interviewing and Guided Opioid Tapering Support vs. Enhanced Usual Care to Promote Opioid Cessation After Orthopedic Surgery

Stanford University·interventional·Posted Sep 6, 2018·Updated Jan 17, 2025

In Brief

A clinical study evaluating Motivational Interviewing and Guided Opioid Tapering Support and Enhanced Usual Care for Opioid Cessation. Completed, enrolled 179 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the relative efficacy of enhanced usual care versus motivational interviewing and guided opioid tapering support to promote opioid cessation after total hip or knee replacement surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 6, 2018
Enrollment StartJul 12, 2019
Primary CompletionAug 23, 2023
Study CompletionMar 3, 2024
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 7.8 years ago

Interventions

Motivational Interviewing and Guided Opioid Tapering Supportbehavioral

Following surgery, participants will undergo motivational interviewing with a trained member of the study staff. These calls will occur weekly for 6 weeks with a follow-up call at 10 weeks or until the participant completes the protocol.

Enhanced Usual Carebehavioral

Following surgery, participants will receive phone calls from a trained member of the study staff to discuss various aspects of surgical recovery and medication use. These calls will occur weekly for 6 weeks with a follow-up call at 10 weeks or until the participant completes the protocol.